Table 5.
Association of Reconstruction with Overall Mortality
| N Patients by Reconstruction | HR for Reconstruction vs No Reconstruction | |||||
|---|---|---|---|---|---|---|
| N Patients | No | Yes | HR Estimate | 95% CI | P | |
| Unadjusted: reconstruction status only (ie, with no covariates) | 9738 | 8774 | 964 | 0.79 | 0.72–0.88 | <0.001 |
| Partial adjustment: adjusts for age, race, and Charlson score | 9738 | 8774 | 964 | 0.91 | 0.82–1.01 | 0.081 |
| Full adjustment: in addition, adjusts for cancer history, treatment, insurance, stage, and diagnosis year | 9738 | 8774 | 964 | 0.95 | 0.86–1.06 | 0.35 |
| Subset analysis: only those with chemotherapy as part of treatment, with full adjustment covariates | 9202 | 8263 | 939 | 0.95 | 0.85–1.06 | 0.37 |
| Landmark analysis (6 mo): excludes those with <6 mo follow-up, with full adjustment covariates | 9620 | 8667 | 953 | 0.94 | 0.84–1.04 | 0.24 |
| Landmark analysis (12 mo): excludes those with <12 mo follow-up, with full adjustment covariates | 8953 | 8042 | 911 | 0.97 | 0.87–1.09 | 0.62 |
Results of separate Cox models for covariate adjustment.